This announcement is a separate document:
申联生物：国信证券股份有限公司关于申联生物医药（上海）股份有限公司使用部分闲置募集资金进行现金管理的核查意见
Shenlian Biotech: Opinions of Guoxin Securities Co., Ltd. on the verification of the use of some idle funds raised by Shenlian Biopharmaceuticals (Shanghai) Co., Ltd. for cash management
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated